ReMuS Press Conference | 27 May 2026
On the occasion of World Multiple Sclerosis Day (30 May), the ReMuS registry is publishing fresh data confirming a significant shift in the care of MS patients in the Czech Republic.
Five by five: Czech five-year data on cladribine at AAN 2026 in Chicago
The annual congress of the American Academy of Neurology is being held in Chicago from 18–22 April 2026. Representing ReMuS, MUDr. Dominika Šťastná, Ph.D. presented a poster on the five-year results of cladribine treatment in Czech multiple sclerosis patients.
From sunlight to the fight against multiple sclerosis: the effect of vitamin D levels on the activity of multiple sclerosis
A new study published in the journal Neurological Sciences provides insights into the effect of vitamin D levels on multiple sclerosis (MS) activity in real-world clinical practice. This work, led by Prim. MUDr. Marta [...]
ReMuS in America - poster at the prestigious American Academy of Neurology Congress
ReMuS in America - a poster at the prestigious American Academy of Neurology Congress In April 2025, the AAN Congress took place, where Dr. Dominika Št'astná presented the results of the [...]
Get to know the ReMuS registry
Get to know the ReMuS Registry For the presentation of the ReMuS Registry at the ECTRIMS International Congress on Neuroimmunological Diseases, we have prepared a short presentation that will reveal what is hidden under the hood of this [...]
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry
A new study published in the Journal of Central Nervous System Disease provides insights into the efficacy of cladribine in the treatment of multiple sclerosis (MS) in real-world clinical practice. The paper uses data from the Czech nationwide ReMuS registry and...
Neurologists: all patients must receive high quality care | 2024 ReMuS Registry Press Conference
If a person becomes ill with multiple sclerosis (MS), it should not matter whether they live in Cheb, Kolín or Frýdek Místek. The same care should be provided in all centres throughout the Czech Republic. Thanks to the Patient Register...
Big Multiple Sclerosis Data network: an international registry research network
Article doc. Anna Glaser from Karolinska Institutet, Sweden, focuses on the importance and contribution of European multiple sclerosis registries, specifically the Big Multiple Sclerosis Data Network (BMSD) project, in which ReMuS is actively involved...
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe
In their new study, a team led by Richard Nicholas looked at how health systems in different countries influence clinical diagnosis and access to treatment for multiple sclerosis...
Is breastfeeding in MS harmful or not? An answer from real-world Czech data
The original article by Pavel Hradílek, M.D., Ph.D. from the University Hospital Ostrava based on the ReMuS registry data was published in the journal Multiple Sclerosis and Related Disorders. Because the influence of breastfeeding and its duration on the course of multiple sclerosis is unclear, the authors analyzed real data on breastfeeding women with MS and the course of their disease...